In a groundbreaking leap for medical research, scientists have successfully cultivated miniature human brain models in the ...

CHINA: A 70-year-old man from Henan Province in central China has developed Parkinson’s disease after enduring decades of ...

In a groundbreaking new study, conducted within the framework of the FWF-funded Cluster of Excellence "Microbiomes drive ...

Scientists on the International Space Station (ISS) have grown brain-like organoids in space to research new treatments for ...

Insightec received FDA approval for use with Philips MRI scanners. Insightec's Exablate Prime treats essential tremor and ...

Stem cell therapies provide hope for patients with heart disease, blindness, Parkinson's, HIV, diabetes and spinal cord ...

The Medical College of Wisconsin created a neurology department 50 years ago. Today with Froedtert it is world leader in ...

Parkinson’s disease is a progressive neurological condition that affects millions of people worldwide. While most treatments ...

Dannce.ai emerged from stealth with a platform that aims to use artificial intelligence to help diagnose and monitor movement ...

In a groundbreaking new study scientists have revealed that the widely prescribed Parkinson's disease drug entacapone significantly disrupts the human gut microbiome by inducing iron deficiency. The ...

The firm will test the activity of NEU-411 in patients with Parkinson's caused by LRRK2 mutations or whose disease is influenced by LRRK2 overactivity.